Showing results (541-550 of 858) with videos related to
Sort By:
Pageof 86
Journal of Clinical Medicine|September 28, 2021
Comparative Analysis of the Kinetic Behavior of Systemic Inflammatory Markers in Patients with Depressed versus Preserved Left Ventricular Function Undergoing Transcatheter Aortic Valve ImplantationHaitham Abu Khadija, Gera Gandelman, Omar Ayyad, et al.Journal of Diabetes and Its Complications|August 23, 2015
An association of large-fibre peripheral nerve dysfunction with non-invasive measures of liver fibrosis secondary to non-alcoholic fatty liver disease in diabetesKathryn H Williams, Kharis Burns, Maria Constantino, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 15, 2021
MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approachTsubasa Tsutsumi, Mohammed Eslam, Takumi Kawaguchi, et al.Internal Medicine Journal|October 11, 2023
Temporal change in aetiology and clinical characteristics of hepatocellular carcinoma in a large cohort of patients in New South Wales, AustraliaYuen Kang Joseph Yeoh, Gregory J Dore, Ian Lockart, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|December 1, 2021
Aptamer-mediated doxorubicin delivery reduces HCC burden in 3D organoids modelKevin Zhou, Xiaoqi Huo, Romario Nguyen, et al.Journal of Hypertension|July 4, 2019
Allopurinol treatment adversely impacts left ventricular mass regression in patients with well-controlled hypertensionChristopher R Gingles, Ruth Symon, Stephen J Gandy, et al.International Journal of Molecular Sciences|May 27, 2023
PEMT Mediates Hepatitis C Virus-Induced Steatosis, Explains Genotype-Specific Phenotypes and Supports Virus ReplicationMosleh Abomughaid, Enoch S E Tay, Russell Pickford, et al.Therapeutic Advances in Chronic Disease|May 19, 2025
Characterisation of non-cirrhotic MAFLD-related hepatocellular carcinoma: a retrospective cohort studyShadi Zerehpooshnesfchi, Fatema Safri, Ziyan Pan, et al.BMC Infectious Diseases|June 24, 2026
Non-risk-based HCV screening at point of care: a prospective pilotJeenat Paulose, Nishita Jagarlamudi, Dmitrii Shek, et al.Hepatology International|May 25, 2023
Polypill protects MAFLD patients from cardiovascular events and mortality: a prospective trialAlireza Ramandi, Jacob George, Shahin Merat, et al.Pageof 86